Clinical Trial Update: ABX Combined With Cisplatin Compared With Gemcitabine Combined With Cisplatin in NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing ABX plus cisplatin against gemcitabine plus cisplatin in non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• ABX
• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Fudan University | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED